The Tumor Suppressor Interferon Regulatory Factor 1 Interferes with SP1 Activation to Repress the Human CDK2 Promoter
Open Access
- 1 July 2003
- journal article
- Published by Elsevier BV
- Vol. 278 (29), 26589-26596
- https://doi.org/10.1074/jbc.m301491200
Abstract
No abstract availableThis publication has 61 references indexed in Scilit:
- IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathwayOncogene, 2002
- The Cell Cycle Control Element of Histone H4 Gene Transcription Is Maximally Responsive to Interferon Regulatory Factor Pairs IRF-1/IRF-3 and IRF-1/IRF-7Published by Elsevier BV ,2001
- Modulation of Sp1 activity by a cyclin A/CDK complexJournal of Molecular Biology, 2001
- An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expressionOncogene, 2000
- Identification of the secretory leukocyte protease inhibitor (SLPI) as a target of IRF-1 regulationOncogene, 1999
- Cloning of the cyclin A1 Genomic Structure and Characterization of the Promoter RegionPublished by Elsevier BV ,1999
- Interferon Regulatory Factor-2 Directs Transcription from the gp91 PromoterPublished by Elsevier BV ,1996
- Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2Nature, 1995
- Gamma‐interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophagesFEBS Letters, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993